U.S. Food and Drug Administration at ObesityWeek 2026
Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website
U.S. Food and Drug Administration brings 2 presentations to ObesityWeek 2026 in National Harbor. Its program reviews the year in obesity approvals and regulatory updates.
| Organization | ObesityWeek 2026 Attendance |
|---|---|
U.S. Food and Drug Administration Silver Spring, MD | |
Federal agency that reviews and approves drugs and devices, including obesity medications. | Session Mon Nov 16 3:30pm–4:30pm The Year in Obesity Approvals and Regulatory Updates FDA staff review the past year's obesity drug approvals, label changes and safety notices, and preview regulatory and scientific issues ahead. Population health and epidemiologyClinical obesity care and professional practiceObesity pharmacotherapy and drug developmentPediatric and adolescent obesity Talk Mon Nov 16 3:30pm–4:10pm The Year in Obesity Approvals and Regulatory Updates Population health and epidemiologyClinical obesity care and professional practiceObesity pharmacotherapy and drug developmentPediatric and adolescent obesity |
Find decision makers at U.S. Food and Drug Administration
Tell us what you sell and we’ll find the people at U.S. Food and Drug Administration most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction